Literature DB >> 24434720

Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis.

Paolo Gisondi1, Francesca Sala, Franco Alessandrini, Virginia Avesani, Giada Zoccatelli, Alberto Beltramello, Giuseppe Moretto, Giuseppe Gambina, Giampiero Girolomoni.   

Abstract

BACKGROUND: Psoriasis is frequently associated with cardiometabolic comorbidities and depression that are risk factors for cognitive impairment.
OBJECTIVE: To investigate cognitive performance in psoriatic patients.
METHOD: Cognitive performances were assessed by neuropsychological tests in 41 patients with psoriasis and 37 controls. Diagnostic criteria for mild cognitive impairment (MCI) were (1) subjective complaint of a memory deficit, confirmed by a relative or caregiver, (2) pathological performance on neuropsychological tests investigating cognitive domains, (3) normal performance of daily living activities and (4) no dementia. Neuroimaging was studied by high-field magnetic resonance imaging and cortical thickness analysis.
RESULTS: MCI was found in 18 out of 41 (44%) patients with psoriasis compared to 4 out of 37 (11%) controls (p = 0.002). In particular, patients with psoriasis had lower scores in the delayed recall of the Rey Auditory Verbal Learning Test (p = 0.04), Backwards Digit Span Test (p = 0.002), Weigl's Sorting Test (p = 0.01) and Trail Making Test B (p = 0.008). In the 7 patients submitted to cortical thickness analysis, a reduction in brain thickness in parahippocampal, superior temporal and frontal gyri of the left hemisphere was observed.
CONCLUSIONS: Patients with psoriasis may have a precocious impairment of long-term verbal memory, executive functions and attention.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24434720     DOI: 10.1159/000357220

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  18 in total

Review 1.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

2.  Psoriasis and Risk of Mental Disorders in Denmark.

Authors:  Michelle Z Leisner; Jette L Riis; Sara Schwartz; Lars Iversen; Søren D Østergaard; Morten S Olsen
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

Review 3.  The link between cutaneous inflammation and cognitive impairment.

Authors:  S Wen; P M Elias; J S Wakefield; T M Mauro; M-Q Man
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-07-02       Impact factor: 9.228

Review 4.  Cognitive impairment in psoriasis patients: a systematic review of case-control studies.

Authors:  Daniel Pankowski; K Wytrychiewicz-Pankowska; W Owczarek
Journal:  J Neurol       Date:  2022-08-09       Impact factor: 6.682

Review 5.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

6.  Cognitive impairment in patients with psoriatic arthritis.

Authors:  Leonardo Ogawara Kawamoto Lahoz Garcia; Armando Takao Suehiro Júnior; Deusimar Cristian Dos Santos Gómez; Gabriel Seiji Sato Yoshikawa; Caio Kumassaka Kamikoga; Bruno Kusznir Vitturi
Journal:  Acta Neurol Belg       Date:  2021-03-13       Impact factor: 2.396

7.  Psoriasis and Dementia: A Cross-sectional Study of 121,801 Patients.

Authors:  Khalaf Kridin; Dennis Linder; Guy Shalom; Stefano Piaserico; Meir Babaev; Tamar Freud; Doron Comaneshter; Arnon D Cohen
Journal:  Acta Derm Venereol       Date:  2020-08-19       Impact factor: 3.875

8.  Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

9.  Brain Correlates of Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI).

Authors:  Lisa M James; Brian E Engdahl; Arthur C Leuthold; Apostolos P Georgopoulos
Journal:  EBioMedicine       Date:  2016-10-14       Impact factor: 8.143

10.  Rheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study.

Authors:  Stefania Policicchio; Aminah Noor Ahmad; John Francis Powell; Petroula Proitsi
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.